Entirety Biomedical

High Performance Absorbable Metal Implants

medtech / health AI?

Visit website LinkedIn ↗

StageSeed

Raised$1.23 million

Founded2022

Employees3

LocationNewark

About

Entirety Biomedical is working to become the standard of care in ortho fixation implants, starting with maxillofacial and extremities, to offer cosmetic trauma and reconstruction surgery patients pain-free restoration of natural function at a lower cost of care. Patent pending Curasorb metal alloy combines safe & optimal implant absorption to restore the implant site to its natural state without surgical removal of the implant. This next generation of absorbable implants are less-invasive and more sustainable than current standards of care, while maintaining the strength and cost of Titanium implants for the surgeon, translating to better outcomes over a streamlined recovery process.

Product

Value proposition: Cutting-edge absorbable metal implants (Curasorb Alloy) that match the performance and implantation simplicity of titanium implants, yet safely absorb after healing to eliminate lifelong concerns with permanent hardware.
Target customers: surgeons, patients

Founders

Jake Edick — Co-Founder & CEO
Carolyn Woldring — Co-Founder & CTO

Products

Curasorb Alloy absorbable implants

Key features

engineered absorbable alloymatches performance of titaniumsimple implantationtemporary implants with permanent peace of mindreduces complications and costs of permanent hardware

Technologies

Curasorb Alloyabsorbable metal implantsimplantation technology

Target conditions

cosmetic procedurestraumareconstruction

Care settings

surgeryclinichospital

Investors

NuFund Venture GroupMichigan RiseUnion Heritage VenturesRevere PartnersCommunity Equity PartnersAmerican Society of Plastic SurgeonsMass Medical Angels

News

Entirety Biomedical Closes $1.2 Million Seed Financing to Advance Absorbable Magnesium Implants for Orthopedic Fixation - BioSpace · 2026-02-12T05:16:37.000Z
Entirety Biomedical Closes $1.2 Million Seed Financing to Advance Absorbable Magnesium Implants for Orthopedic Fixation · 2026-02-11T00:00:00.000Z
Entirety Biomedical Closes $1.2 Million Seed Financing to Advance Absorbable Magnesium Implants for Orthopedic Fixation - MedTech Innovator · 2026-02-11T22:04:44.000Z
Entirety Biomedical Closes $1.2 Million Seed Financing to Advance Absorbable Magnesium Implants for Orthopedic Fixation | The Manila Times · 2026-02-11T16:11:26.000Z
From Spreadsheets to Scalable QMS: QuickVault Customer Story · 2025-04-29T15:43:54.000Z

Browse similar startups

Related startups

Episteme Prognostics, Inc. — Brooklyn, NY
Exactics, Inc. — Chicago, IL
GNOMX Corp. — New York, NY
Gordion Bioscience — Boston, MA
Helicore Biopharma — San Mateo, CA
ImmunoMetabolix — Bridgewater, NJ
Envera Health — Dallas, TX
Eonix Solution — Sheridan, WY
Equis Consulting Group — Union City, IN
Essential Pediatrics — Newton, MA
ESSEX CARDIOLOGY GROUP, PC — Florham Park, NJ
Ethicos Health — Nashville, TN

Profile updated Jul 12, 2026. Sources: entiretybio.com